Effect of highly active antiretroviral therapy (haart) on cd4+ cell count and liver enzymes in HIV infection at Lokoja, Nigeria

GE Itodo, SS Enitan, VO Samanu, FA Ehiaghe, Richard Yomi Akele, OA Olanyanju

Research output: Contribution to journalArticlepeer-review

Abstract

Aim
To assess the effect of highly active antiretroviral therapy (HAART) on CD4 + cell count and liver enzymes in HIV-infected patients six month post-therapy based on age and sex distribution.
Methods
A cohort of 200 (66 males, 134 females) consenting HAAR naïve patients, aged between 16 and 65 years with confirmed cases of HIV infection (by Western blot method) at Lokoja, Nigeria having a baseline CD4 + cell counts ≤350 cells/µL were initiated on HAART for six months. Two blood samples were collected, one at pre-HAART (baseline) and the other at post-HAART (follow-up) phase. CD4 + cells were counted and liver enzymes levels were evaluated using the Partec® Cyflow Counter and Reflotron® Plus Auto-Analyzer, respectively.
Results
The immunological outcome of 6 months HAART shows that there was slight increase (statistically, considered not significant, P>0.05) in the post-HAART mean±SEMCD4 + cell count in the different age and sex strata investigated, when comparison was made with the pre-HAART mean±SEMCD4 + cell count. Also, the post HAART liver function test show that the liver enzymes levels were not significantly (P>0.05) elevated when compared to the baseline values.
Conclusion
Six months of HAART replete CD4 + cell counts of HIV-infected patients of different age and sex strata, with no risk of liver damage.
Original languageEnglish
Article number57704B755404
Pages (from-to)34-41
Number of pages7
JournalAfrican Journal of Cellular Pathology
Volume4
Issue number4
DOIs
Publication statusPublished - 30 Apr 2015

Fingerprint

Dive into the research topics of 'Effect of highly active antiretroviral therapy (haart) on cd4+ cell count and liver enzymes in HIV infection at Lokoja, Nigeria'. Together they form a unique fingerprint.

Cite this